Multiple Clinical Presentations of Lymphoproliferative Disorders in Pediatric Liver Transplant Recipients: A Single-Center Experience

Transplantation Proceedings

Volumn 42, Issue 5, 2010, Pages 1763-1768

  Pinho Apezzato, M L ^a   Tannuri, U ^a   Tannuri, A C A ^a   Mello, E S ^a   Lima, F ^a   Gibelli, N E ^a   Santos, M M ^a   Ayoub, A A ^a   Maksoud Filho, J G ^a   Velhote, M C ^a   Silva, M M ^a   Andrade, W C ^a   Miyatani, H T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ABDOMINAL MASS; ADD ON THERAPY; ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIARRHEA; EPSTEIN BARR VIRUS; FEMALE; FEVER; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MALE; ORGAN TRANSPLANTATION; PANCYTOPENIA; PEDIATRIC SURGERY; PRIORITY JOURNAL; RECURRENT INFECTION; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VOMITING;

BILIARY ATRESIA; CHILD; CHILD, PRESCHOOL; COLONIC NEOPLASMS; CYCLOSPORINE; DRUG THERAPY, COMBINATION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; POSTOPERATIVE COMPLICATIONS; PREDNISONE; RETROSPECTIVE STUDIES; SURVIVORS; TACROLIMUS;

EID: 77953669080     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.01.077     Document Type: Article

References (17)

1. Starzl T.E. Discussion of Murry JE, Wilson RE, Tilney NL, et al: Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications and the role of lymphocyte depletion by thoracic fistula. Ann Surg 1648 (1968) 416
2. Birkeland S.A., Hamilton-Dutoit S., and Bendtzen K. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation. Transplantation 76 (2003) 153
3. Jain A., Nalesnik M., Reyes J., et al. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg 236 (2002) 429
4. Timuraǧaoǧlu A., Uǧur-Bilgin A., Colak D., et al. Posttransplant lymphoproliferative disorders in transplant recipients. Transplant Proc 38 (2006) 641
5. Hurwitz M., Desai D.M., Cox K.L., et al. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Pediatr Transplant 8 (2004) 267
6. Webber S., and Green M. Post-transplant lymphoproliferative disorders and malignancy. In: Fine R.E., Webber S.A., Olthoff K.M., et al. (Eds). Pediatric Solid Organ Transplantation. 2nd Ed. (2007), Blackwell Publishing, Malden, Mass 114
7. Birkeland S.A., Hamilton-Dutoit S., and Bendtzen K. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation. Transplantation 76 (2003) 153
8. Roque J., Riso G., Humeres R., et al. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Transplant Proc 38 (2006) 930
9. Fernández M.C., Bes D., De Dávila M., et al. Post-transplant lymphoproliferative disorder after pediatric liver transplantation: characteristics and outcome. Pediatr Transplant 13 (2009) 307
10. Harris N.L., Ferry J.A., and Swerdlow S.H. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Semin Diagn Pathol 14 (1997) 8
11. Sokal E.M., Caragizoglou T., Lamy M., et al. Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation 56 (1993) 1394
12. Lattyak B.V., Rosenthal P., Mudge C., et al. Posttransplant lymphoproliferative disorder presenting in the head and neck. Laryngoscope 108 (1998) 1195
13. Yousem S.A., Randhawa P., Locker J., et al. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol 20 (1989) 361
14. Smets F., Vajro P., Cornu G., et al. Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation. Transplantation 69 (2000) 982
15. Gibelli N.E.M., Tannuri U., Pinho-Apezzato M.L., et al. Sirolimus in pediatric liver transplantation: single center experience. Transplant Proc 41 (2009) 901
16. Sindhi R., Webber S., Venkataramanan R., et al. Sirolimus for prophylaxis of rejection and rescue in transplanted children receiving tacrolimus. Transplantation 72 (2001) 851
17. Gupta P., Kaufman S., and Fishbein T.M. Sirolimus for solid organ transplantation in children. Pediatr Transplant 9 (2005) 269